Tech Company Financing Transactions
LambdaVision Funding Round
LambdaVision secured a $7 million Seed investment round on 11/5/2025. Backers included Seven Seven Six and Seraphim Space.
Transaction Overview
Company Name
Announced On
11/5/2025
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Seed
Investors
Seven Seven Six (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance preclinical development and scale up space-enabled manufacturing of its artificial retina.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Woodbridge, CT Undisclosed
USA
Woodbridge, CT Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
LambdaVision is leveraging space to develop an innovative, protein-based artificial retina that utilizes a light-activated protein, bacteriorhodopsin, to restore functional sight to those who would otherwise be blind due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). No cure exists for these diseases, and currently available treatments only slow their progression. There is a significant unmet need for the development of a treatment that restores meaningful vision to those affected. Through the development of an artificial retina, LambdaVision hopes to one day help patients regain vision so that they can complete everyday tasks with independence.
Management Team
Browse more venture capital transactions:
Prev: 11/5/2025: Flux XII venture capital transaction
Next: 11/5/2025: Procurement Sciences AI venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








